当前位置:首页 - 行情中心 - *ST生物(000504) - 财务分析 - 现金流量表

*ST生物

(000504)

  

流通市值:29.32亿  总市值:29.41亿
流通股本:3.29亿   总股本:3.30亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金78,890,097.0546,856,325.03230,653,967.3121,599,540.26
  收到的税费返还316,457.291,085.69184,688.22174,639.89
  收到其他与经营活动有关的现金4,701,244.191,450,200.6111,168,978.8413,690,617.24
  经营活动现金流入小计83,907,798.5348,307,611.33242,007,634.36135,464,797.39
  购买商品、接受劳务支付的现金15,324,423.5910,938,151.81126,094,241.4432,109,686.37
  支付给职工以及为职工支付的现金35,670,965.2318,832,482.5970,218,101.1453,404,040.46
  支付的各项税费9,596,529.295,943,535.0410,896,134.088,906,183.13
  支付其他与经营活动有关的现金26,276,381.413,418,734.1630,005,574.8534,127,262.53
  经营活动现金流出小计86,868,299.5149,132,903.6237,214,051.51128,547,172.49
  经营活动产生的现金流量净额-2,960,500.98-825,292.274,793,582.856,917,624.9
二、投资活动产生的现金流量:
  收回投资收到的现金40,229,390.4220.95192,907,473.68218,149,937.31
  取得投资收益收到的现金3,191,627.441,578,082.195,594,383.554,879,795.86
  处置固定资产、无形资产和其他长期资产收回的现金净额17,5005,0001,471.81-
  收到的其他与投资活动有关的现金--2,526,523.35-
  投资活动现金流入小计43,438,517.841,583,303.14201,029,852.39223,029,733.17
  购建固定资产、无形资产和其他长期资产支付的现金570,200.1226,89018,262,796.7816,052,536.23
  投资支付的现金105,000,00065,000,000291,100,000317,100,000
  取得子公司及其他营业单位支付的现金----4,603,707.29
  投资活动现金流出小计105,570,200.165,226,890309,362,796.78328,548,828.94
  投资活动产生的现金流量净额-62,131,682.26-63,643,586.86-108,332,944.39-105,519,095.77
三、筹资活动产生的现金流量:
  取得借款收到的现金--18,000,00018,000,000
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--18,000,00018,000,000
  偿还债务支付的现金500,000500,00036,000,00036,000,000
  分配股利、利润或偿付利息支付的现金393,322.53314,419.74931,456.234,805,027.2
  支付其他与筹资活动有关的现金1,398,259.5673,951.95163,977,151.29157,666,620.56
  筹资活动现金流出小计2,291,582.031,488,371.69200,908,607.52198,471,647.76
  筹资活动产生的现金流量净额-2,291,582.03-1,488,371.69-182,908,607.52-180,471,647.76
四、汇率变动对现金及现金等价物的影响-11.45-40.5916.93
五、现金及现金等价物净增加额-67,383,776.72-65,957,250.82-286,447,928.47-279,073,101.7
  加:期初现金及现金等价物余额207,333,146.93207,333,146.93493,781,075.4493,781,075.4
  期末现金及现金等价物余额139,949,370.21141,375,896.11207,333,146.93214,707,973.7
补充资料:
  净利润-14,062,869.87--23,925,602.31-
  资产减值准备4,167,695.97-22,857,355.54-
  固定资产和投资性房地产折旧1,241,171.78-2,477,993.74-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧1,241,171.78-2,477,993.74-
  无形资产摊销107,459.48-68,879.32-
  长期待摊费用摊销5,068,149.28-12,179,833.42-
  处置固定资产、无形资产和其他长期资产的损失-32,482.62--155,702.85-
  公允价值变动损失145,895-6,629-
  财务费用-217,576.42-1,462,410.54-
  投资损失-3,416,948.57--3,689,457.92-
  递延所得税-798,625.97--904,850.68-
  其中:递延所得税资产减少-734,523.31--806,033.31-
    递延所得税负债增加-64,102.66--98,817.37-
  存货的减少15,867,341.5--25,411,464.52-
  经营性应收项目的减少-65,335,672.95--37,379,254.33-
  经营性应付项目的增加52,604,665.94-54,044,521.14-
  现金的期末余额139,949,370.21-207,333,146.93-
  减:现金的期初余额207,333,146.93-493,781,075.4-
  现金及现金等价物的净增加额-67,383,776.72--286,447,928.47-
公告日期2025-08-282025-04-292025-04-292024-10-31
审计意见(境内)标准无保留意见
TOP↑